Metabolic syndrome and intracranial atherosclerosis: a new link?
Bushnell
Cheryl D
CD
Guzick
David
D
D000925:Anticoagulants / Q000627:therapeutic use; D002339:Carotid Arteries / Q000473:pathology / Q000503:physiopathology; D002536:Cerebral Arteries / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000209:etiology* / Q000503:physiopathology; D024821:Metabolic Syndrome / Q000150:complications* / Q000503:physiopathology; D018384:Oxidative Stress / Q000502:physiology; D012307:Risk Factors; D055502:Secondary Prevention; D020521:Stroke / Q000209:etiology* / Q000503:physiopathology
D000925:Anticoagulants